search
for
 About Bioline  All Journals  Testimonials  Membership  News


Revista Científica UDO Agrícola
Universidad de Oriente Press
ISSN: 1317-9152
Vol. 9, No. 3, 2009, pp. 700-704
Bioline Code: cg09084
Full paper language: English
Document type: Research Article
Document available free of charge

Revista Científica UDO Agrícola, Vol. 9, No. 3, 2009, pp. 700-704

 en Comparison of the antibacterial activities of different brands of Ciprofloxacin
Nazir Mughal, Muhammad Shahid; Asghar, Muhammad Tahir; Zia, Muhammad Atif & Ismail, Tariq

Abstract

The present study was carried out to evaluate and compare the antibacterial susceptibility of Gram-positive and Gram-negative bacteria to Cyrocin (Ciprofloxacin). The following three bacterial strains were used: Staphyloccocus aureus [ATCC 25923], Escherichia coli [ATCC 25922] and Pseudomonas aeruginosae [ATCC 27853]. Standard commercial discs of definite potency are used as reference standard (Ciprofloxacin 5μg [CTO425B - OXOID Ltd. UK]). The test products were 250 mg and 500 mg tablets of the following brands: Cyrocin (Highnoon Laboratories Limited), Ciproxin (Bayer Pharma (Pvt) Ltd. - Pakistan), Mercip (Merck Marker (Pvt.) Ltd., Pakistan) and Axcin (Sandoz - Norvatis Pharma Ltd., Pakistan). The media used were: Nutrient Broth (Cat. No. 1.05443, Merck, Germany) and Mueller Hinton Agar [Oxoid]. The study showed no statistically significant difference in the results of different brands.

Keywords
Antibacterial properties, Staphyloccocus aureus, Escherichia coli, Pseudomonas aeruginosae, Ciprofloxacin

 
 es Comparación de la actividad antibacterial de diferentes marcas de Ciprofloxacina
Nazir Mughal, Muhammad Shahid; Asghar, Muhammad Tahir; Zia, Muhammad Atif & Ismail, Tariq

Resumen

El presente estudio se realizó para evaluar y comparar la susceptibilidad antibacterial de las bacterias Gram-positiva y Gram-negativa al Cyrocin (Ciprofloxacina). Se usaron las cepas bacetriales Staphyloccocus aureus [ATCC 25923], Escherichia coli [ATCC 25922] y Pseudomonas aeruginosae [ATCC 27853]. Se utilizaron discos comerciales estandars de potencia definida como estandar de referencia (Ciprofloxacin 5μg [CTO425B - OXOID Ltd. UK]). Los productos evaluadoes fueron tabletas de 250 mg y 500 mg de las siguientes marcas: Cyrocin (Highnoon Laboratories Limited), Ciproxin (Bayer Pharma (Pvt) Ltd. - Pakistan), Mercip (Merck Marker (Pvt.) Ltd., Pakistan) y Axcin (Sandoz - Norvatis Pharma Ltd., Pakistan). Los medios usados fueron: Nutrient Broth (Cat. No. 1.05443, Merck, Germany) and Mueller Hinton Agar [Oxoid]. El estudio mostró diferencias estadísticamente no significativas en los resultados de las diferentes marcas,

Palabras-clave
Propiedades antibacteriales, Staphyloccocus aureus, Escherichia coli, Pseudomonas aeruginosae, Ciprofloxacina

 
© Copyright 2009 - Revista Científica UDO Agrícola
Alternative site location: http://www.udoagricola.orgfree.com

Home Faq Resources Email Bioline
© Bioline International, 1989 - 2024, Site last up-dated on 01-Sep-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Google Cloud Platform, GCP, Brazil